Publications by authors named "Thomas Abrams"

Claim this Profile
R
Racial and ethnic differences in treatment and survival for hepatocellular carcinoma patients undergoing systemic therapy.
Kelsey S Lau-Min, Angela C Tramontano, Franklin Iheanacho, Thomas Adam Abrams, Christopher R Manz

JNCI Cancer Spectr· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of cabozantinib in combination with nivolumab for advanced extrapancreatic neuroendocrine tumors (epNET).
Kimberly J Perez, Nora Horick, Joanna Baginska, Anita Giobbie-Hurder, Ilana Gomez Diaz, Thomas Abrams

Clin Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.
Rishi Surana, Micaela Morgado, Ashwin Somasundaram, Bruno Bockorny, Colin D Weekes, Thomas A Abrams

JCO Precis Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Al B Benson, Michael I D'Angelica, Thomas Abrams, Aijaz Ahmed, Mehmet Akce

J Natl Compr Canc Netw· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Summary of the HCC-CARE Symposium: Collaborative Approaches to Reaching Equity in Hepatocellular Carcinoma in Boston by 2030.
Kelsey S Lau-Min, Thomas Abrams, Andrea Bullock, Alyson Kaplan, Leslie Salas Karnes

J Hepatocell Carcinoma· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing treatment patterns for hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results-Medicare study.
Franklin Iheanacho, Angela C Tramontano, Thomas Adam Abrams, Christopher R Manz

Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer.
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, Juan W Valle, Chigusa Morizane, Thomas A Abrams

Future Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab.
Ryan J Park, Milan Parikh, Leon Pappas, Moshe Sade-Feldman, Anupriya S Kulkarni, Thomas A Abrams

medRxiv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor.
Paul E Oberstein, Andressa Dias Costa, Emily A Kawaler, Victoire Cardot-Ruffino, Osama E Rahma, Thomas A Abrams

Cancer Immunol Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma.
Harshabad Singh, Kristen E Lowder, Kevin Kapner, Ronan J Kelly, Hui Zheng, Thomas A Abrams

Nat Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer.
Harshabad Singh, Pranshu Sahgal, Kevin Kapner, Steven M Corsello, Hersh Gupta, Thomas A Abrams

Clin Cancer Res· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-κB Signaling in Patients with Pancreatic Cancer.
Lestat R Ali, Patrick J Lenehan, Victoire Cardot-Ruffino, Andressa Dias Costa, Matthew H G Katz, Thomas A Abrams

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.
Brandon M Huffman, Harshabad Singh, Lestat R Ali, Nora Horick, S Jennifer Wang, Thomas A Abrams

J Immunother Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.
Brandon M Huffman, Hanrong Feng, Kalindi Parmar, Junning Wang, Kevin S Kapner, Thomas A Abrams

Clin Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
Al B Benson, Michael I D'Angelica, Thomas Abrams, Daniel E Abbott, Aijaz Ahmed

J Natl Compr Canc Netw· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can MRI features predict clinically relevant hepatocellular carcinoma genetic subtypes?
Xiaoyang Liu, Yang Guo, Lei Zhao, Joseph Misdraji, Tina Kapur, Thomas A Abrams

Abdom Radiol (NY)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G-CSF rescue of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans.
Victoire Cardot-Ruffino, Naima Bollenrucher, Luisa Delius, S Jennifer Wang, Lauren K Brais, Thomas A Abrams

J Immunother Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib and Expansion Study of Gemcitabine, Nab-Paclitaxel, and Ficlatuzumab in Patients With Metastatic Pancreatic Cancer.
Kimberly Perez, Anna M Chiarella, James M Cleary, Nora Horick, Colin Weekes, Thomas Abrams

Oncologist· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined PD-1, BRAF and MEK inhibition in BRAF colorectal cancer: a phase 2 trial.
Jun Tian, Jonathan H Chen, Sherry X Chao, Karin Pelka, Marios Giannakis, Thomas A Abrams

Nat Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer.
Rachel B Keller, Tali Mazor, Lynette Sholl, Andrew J Aguirre, Harshabad Singh, Thomas A Abrams

JCO Precis Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Futibatinib for -Rearranged Intrahepatic Cholangiocarcinoma.
Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, Juan W Valle, Chigusa Morizane, Thomas A Abrams

N Engl J Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, phase Ib/II, open-label study of tivozanib with durvalumab in advanced hepatocellular carcinoma (DEDUCTIVE).
Sharmeen Mahmood, Daneng Li, Arielle Lee, Julie Rowe, Muhammed Beg, Thomas Abrams

Future Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gallstones and risk of cancers of the liver, biliary tract and pancreas: a prospective study within two U.S. cohorts.
Xiao Luo, Wanshui Yang, Amit D Joshi, Kana Wu, Tracey G Simon, Thomas A Abrams

Br J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolution of synaptic and cognitive capacity: Insights from the nervous system transcriptome of .
Joshua Orvis, Caroline B Albertin, Pragya Shrestha, Shuangshuang Chen, Melanie Zheng, Thomas W Abrams

Proc Natl Acad Sci U S A· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physical activity in older adults with metastatic gastrointestinal cancer: a pilot and feasibility study.
Justin C Brown, Elizabeth Brighton, Nancy Campbell, Nadine J McCleary, Thomas A Abrams

BMJ Open Sport Exerc Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis